NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells

Leukemia. 2010 Apr;24(4):860-1. doi: 10.1038/leu.2009.291. Epub 2010 Jan 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromosomes, Human, Pair 21 / genetics
  • Chromosomes, Human, Pair 8 / genetics
  • Cohort Studies
  • Core Binding Factor Alpha 2 Subunit / genetics*
  • Core Binding Factor Alpha 2 Subunit / metabolism
  • DNA, Neoplasm / genetics
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / pathology
  • Minor Histocompatibility Antigens
  • Oncogene Proteins, Fusion / genetics*
  • Oncogene Proteins, Fusion / metabolism
  • Polymerase Chain Reaction
  • Protein Structure, Tertiary
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins / metabolism
  • RUNX1 Translocation Partner 1 Protein
  • Transcription Factors / genetics*
  • Transcription Factors / metabolism
  • Translocation, Genetic / genetics
  • Tumor Cells, Cultured

Substances

  • AML1-ETO fusion protein, human
  • Core Binding Factor Alpha 2 Subunit
  • DNA, Neoplasm
  • DNA-Binding Proteins
  • Minor Histocompatibility Antigens
  • Oncogene Proteins, Fusion
  • Proto-Oncogene Proteins
  • RUNX1 Translocation Partner 1 Protein
  • RUNX1T1 protein, human
  • SON protein, human
  • Transcription Factors